Skip to main content

Table 2 Change in follow-up variables at 3, 6, and 12 months after the baseline visit among all participants, by study group

From: Leptin and smoking cessation: secondary analyses of a randomized controlled trial assessing physical activity as an aid for smoking cessation

 

3 months

 

6 months

 

12 months

 
 

Intervention

Control

p

Intervention

Control

p

Intervention

Control

p

Body weight [Kg]

2.31 (2.72)

2.15 (2.48)

0.665

2.84 (5.99)

3.02 (3.51)

0.822

2.91 (6.66)

3.33 (4.47)

0.633

BMI [kg/m2]

0.8 (0.91)

0.73 (0.89)

0.57

1.01 (1.83)

1.03 (1.21)

0.928

1 (1.98)

1.14 (1.53)

0.624

Body fat [%]

1.76 (4.43)

1.09 (2.13)

0.269

2.53 (5.75)

1.86 (3.19)

0.477

2.49 (5.24)

2.53 (2.95)

0.957

HOMA-IR

0.1 (1.16)

0.04 (1.22)

0.735

0.33 (1.08)

0.24 (1.03)

0.596

0.67 (1.56)

0.78 (1.92)

0.731

Fasting leptin [ug/l]

1.78 (3.79)

2.37 (3.61)

0.273

1.73 (5.77)

3.2 (4.42)

0.08

1.25 (4.86)

3.23 (4.89)

0.014*

Ratio leptin/body fat

0 (0.19)

0.06 (0.1)

0.024*

-0.04 (0.23)

0.08 (0.12)

0.001**

-0.02 (0.22)

0.07 (0.12)

0.008**

  1. BMI: Body Mass Index; HOMA-IR: homeostasis model assessment for insulin resistance.
  2. ¶ p-value, assessed by univariate linear regression analysis.
  3. Values are expressed in means (standard deviation).
  4. * p <0.05;**p <0.01.